Supplements With Evidence In Mild Cognitive Impairment
Quick Read Mild cognitive impairment is a grey zone between normal age-related memory changes and dementia, and it may be
Subscribe to the distribution list, to get regular updates on supplement research for health,
🧠 NeuroBright Our evidence-based brain supplement formulated from 1.7M research papers
If you regularly wake up tired, struggle to focus, or find your thinking feels sluggish by mid-afternoon, the explanation may lie deeper than sleep or stress. Your brain is the most energy-hungry organ in your body, and it depends on a continuous supply of a molecule called ATP to power every thought, memory, and moment of concentration. CoQ10, a compound your body produces naturally, sits at the very centre of how that energy is made. It acts as a molecular shuttle inside your cells’ power stations, keeping the production line running, and as an antioxidant that mops up the damage the process creates. The problem is straightforward: your body’s natural production of CoQ10 declines with age, and the brain, which relies on this process more than almost any other organ, begins to struggle as a result.
The research linking CoQ10 to brain health comes from several directions. A 2023 study of 64 older adults found that lower CoQ10 levels in the blood were significantly associated with poorer cognitive function and weaker executive skills, the mental abilities involved in planning, focusing, and managing information, even after accounting for physical activity and nutrition. Animal studies reinforce the picture: aged mice given CoQ10 showed restored mitochondrial function, improved motor performance, and reduced accumulation of proteins associated with neurodegeneration.
The strongest human clinical evidence concerns mood rather than energy. A 2026 systematic review pooled five randomised controlled trials involving 474 participants and found that CoQ10 supplementation produced a statistically significant, moderate reduction in depressive symptoms compared to placebo. This held across different patient groups. Depression and cognitive fatigue share much of the same underlying biology, so the finding raises a reasonable hypothesis about CoQ10’s broader effect on brain health.
The picture for fatigue specifically is murkier. The same review found no statistically significant effect on fatigue, but that finding rested on just two trials with highly conflicting results. Two trials is not enough data to draw conclusions either way. One major unresolved question hangs over all of this: does CoQ10 taken as a supplement actually reach the human brain in meaningful quantities? Animal studies suggest it can, but human evidence remains indirect. This is likely why clinical trials in Parkinson’s and Alzheimer’s patients have been disappointing despite strong animal data.
One group has a stronger case for supplementation: anyone taking a statin medication. Statins reduce the body’s natural CoQ10 production as a side effect, and statin-related fatigue and cognitive fog are widely reported. If you are on a statin, this is worth discussing with your GP. For everyone else over 40, CoQ10 is well-tolerated at 100 to 200mg daily, has no serious known adverse effects, and is best taken with a meal containing some fat.
Verdict: CoQ10 is central to how your brain makes energy, its levels decline with age, and the evidence for mood benefits across five clinical trials is meaningful, but the case for everyday cognitive fatigue specifically is promising rather than proven, and whether supplemented CoQ10 reaches the brain in sufficient quantities remains the key open question.
You sleep eight hours and wake up tired. You sit down to focus and feel like you’re thinking through wet concrete. You reach for another coffee and wonder, is this just what getting older feels like? What if the problem isn’t your willpower, your sleep hygiene, or your caffeine intake, but something happening deep inside the cells that power your brain?
This is where CoQ10 enters the conversation. Not as a miracle supplement with breathless marketing claims, but as a molecule your body makes itself, that quietly declines as you age, and that sits at the very centre of how your brain generates energy. Out of 1.77 million research papers analysed by Vitacuity, we selected 15 of the most relevant studies on CoQ10 and brain health. Here’s what the science honestly shows, and where it still has gaps.
To understand why CoQ10 matters for cognitive fatigue, you need to know a little about how your brain actually makes energy, because the brain is, by a remarkable margin, the most energy-hungry organ in your body.
Every cell in your brain contains tiny structures called mitochondria, think of them as miniature power stations. Inside those power stations, a carefully orchestrated chain of chemical reactions converts oxygen and nutrients into ATP (adenosine triphosphate), the molecule that everything in your body runs on. Thought, memory, attention, mood, all of it requires a continuous supply of ATP.
CoQ10, also known as ubiquinone, is an essential component of this process. It acts as an electron carrier, a kind of molecular shuttle, ferrying electrons between the different stages of the mitochondrial production line [7]. Without it, the chain stalls, energy production drops, and your cells begin to struggle. CoQ10 also acts as an antioxidant, neutralising the damaging free radicals that are a byproduct of energy production itself [6].
Here’s the part that matters most for anyone over 40: your body’s natural production of CoQ10 declines with age [6]. The power stations become less efficient. The molecular shuttles become scarcer. And the brain, which depends more heavily on mitochondrial energy than almost any other organ, begins to feel the strain.
Evidence grade: Promising, human observational data, but small sample size
One of the more striking findings in the research comes from a 2023 study published in *Nutrients* that set out to do something surprisingly straightforward: measure CoQ10 levels in older adults and see whether they correlated with cognitive performance [8].
The sample was 64 older adults, aged 65–99 (average age 76.67), mostly women. Researchers measured plasma CoQ10 levels alongside cognitive functioning and executive function, the mental skills involved in planning, focusing, and managing multiple pieces of information at once. Crucially, they controlled for physical activity and nutritional status, both of which independently affect cognitive ageing.
The main finding: lower plasma CoQ10 levels were significantly associated with poorer cognitive functioning and executive function, even after accounting for those other factors [8].
It’s an important study, and it’s also a modest one. Sixty-four people is a small sample. And because it’s observational, it tells us there’s a relationship between CoQ10 levels and cognitive function, but not necessarily which direction the causation runs. Does low CoQ10 cause cognitive decline? Or does cognitive decline accompany a broader biological deterioration that also depletes CoQ10? We don’t yet know for certain. But the signal is real, and the mechanism is biologically credible.
Evidence grade: Early stage for humans, strong animal data, mechanism well-established
Here’s something the research describes clearly: as we age, mitochondrial function in the brain declines. CoQ10 content drops alongside it [14]. A 2016 mouse study found that aged mice (15 months old) showed significantly reduced mitochondrial oxygen consumption and lower CoQ10 levels compared to younger mice, and these changes coincided with measurable declines in motor function and problematic accumulations of a protein called alpha-synuclein (associated with Parkinson’s disease) in the motor cortex [14].
The striking part of that study: when aged mice were given water-soluble CoQ10, mitochondrial function was restored, motor performance improved, and the problematic protein accumulations were reduced [14].
Now, these are mice, not humans, and that’s an important caveat. But the study illustrates the mechanism clearly. Declining CoQ10 correlates with declining mitochondrial function. Restoring CoQ10 appears to restore that function, at least in animal models.
A 2025 rat study reinforced this picture, showing that CoQ10 has neuroprotective effects in ageing animals, working through pathways involving oxidative stress, inflammation, and a cellular cleanup process called autophagy [5]. Again, animal data, not human trials. But the biological story it tells is consistent with what we see in human observational research.
Evidence grade: Promising, five RCTs, 474 participants, consistent direction of effect
A 2026 systematic review and meta-analysis, one of the most rigorous types of study possible, pooled data from five randomised controlled trials involving 474 participants to examine whether CoQ10 supplementation could reduce depressive symptoms and fatigue [1].
The depression finding was notable. CoQ10 supplementation produced a statistically significant reduction in depressive symptoms compared to placebo, with a standardised mean difference of -0.68 (a moderate effect size) [1]. The results were consistent across different rating scales and across different patient populations, people with depression alongside multiple sclerosis, breast cancer, polycystic ovary syndrome, major depressive disorder, and bipolar disorder.
Five RCTs and 474 participants is not a huge evidence base by clinical standards, but it’s enough to take seriously, particularly given the consistency of the direction of effect and the plausibility of the mechanism. Depression and cognitive fatigue share many of the same underlying biology: oxidative stress, neuroinflammation, and mitochondrial dysfunction [1]. The finding that CoQ10 helps with one raises a reasonable hypothesis that it may help with the other.
Evidence grade: Conflicted, only 2 trials, high variability, no firm conclusion
This is where intellectual honesty matters. The same 2026 meta-analysis looked at fatigue as a separate outcome, and found no statistically significant benefit [1]. The standardised mean difference for fatigue was -0.33, with a confidence interval so wide (-1.38 to 0.72) that it crossed zero entirely. The I² statistic (a measure of how much the studies disagreed with each other) was 89%, which is very high, meaning the individual trials gave quite different results [1].
The crucial caveat here is that this fatigue finding was based on only two trials. Two trials is not enough to draw firm conclusions either way. The true effect of CoQ10 on fatigue could be real and meaningful, or it could be negligible. We simply don’t have enough data yet to know.
Elsewhere in the research, a 2025 review notes that CoQ10 has shown reported benefits in fatigue-related conditions including ME/CFS, fibromyalgia, Gulf War Illness, and Long COVID, all of which share mitochondrial dysfunction and oxidative stress as underlying features [3]. This is a biologically coherent rationale. But “reported benefits” in a narrative review is a step below the controlled trial evidence we’d need to be confident.
The honest summary: CoQ10’s effect on fatigue is plausible and mechanistically well-grounded, but the clinical trial evidence is currently insufficient to confirm it. Watch this space.
Evidence grade: Conflicted, strong animal data, human trials have been disappointing
If you’ve looked into CoQ10 before, you may have seen it discussed in the context of Parkinson’s disease and Alzheimer’s disease. The biological rationale is sound, both conditions involve significant mitochondrial dysfunction, and CoQ10 plays a central role in mitochondrial health [2, 6, 11].
In animal models, the results have been encouraging. Studies have shown that CoQ10 can protect dopaminergic neurons (the brain cells that die in Parkinson’s disease), reduce oxidative stress, and slow neurodegenerative processes [2, 13].
But when researchers have translated these findings into randomised controlled trials in humans, the results have been consistently underwhelming [4, 11]. A 2025 review examining the blood-brain barrier specifically highlighted this tension: CoQ10 works well in animal models, but clinical trials in Parkinson’s, Alzheimer’s, and ALS patients have had disappointing outcomes, and a key reason may be that we’re still uncertain whether orally supplemented CoQ10 actually crosses the blood-brain barrier in humans in meaningful quantities [4].
This is a genuinely important unresolved question. The molecule does reach the brain in some animal models, and there is indirect evidence in humans (lower blood levels are associated with worse cognitive outcomes [8]). But we don’t have clear proof that supplementing CoQ10 raises brain levels sufficiently to produce the neuroprotective effects seen in animal studies [4].
This does not mean CoQ10 is useless for brain health. It means the most dramatic claims, that it can halt or reverse neurodegenerative disease, are not yet supported by human trial data, even if the biology makes them plausible.
Evidence grade: Promising, mechanism established, clinical implications acknowledged
One point worth raising for anyone in the 40–65 age group: if you’re taking a statin medication to manage cholesterol, you may have a CoQ10 depletion problem you don’t know about. Statins work by blocking an enzyme called HMG-CoA reductase, but this same enzyme is involved in CoQ10 synthesis [6]. The research literature consistently notes this relationship [6, 7].
Statin use is widespread in the UK, particularly in the over-50 population. Statin-associated muscle fatigue and cognitive fog are commonly reported side effects, and CoQ10 depletion is one proposed mechanism. This doesn’t mean everyone on a statin should self-prescribe CoQ10, but it does mean the conversation is worth having with a healthcare provider, and that CoQ10’s relevance to this group may be greater than average.
The honest gaps in the CoQ10 research are significant, and they’re worth naming clearly.
Does supplemented CoQ10 actually reach the brain? This is perhaps the biggest unresolved question. A 2025 review examining the blood-brain barrier found genuine uncertainty about whether orally taken CoQ10 crosses into the human brain in sufficient quantities to produce neurological effects [4]. Animal studies suggest it can. Human evidence is indirect and inconclusive. New formulations, including water-soluble versions and structural derivatives like MitoQ, are being developed to improve absorption and tissue distribution [11], but comparative human trial data is still limited.
What’s the right dose? Trials have used a wide range of doses, making it difficult to identify an optimal amount. The 2026 meta-analysis on depression and fatigue didn’t identify a clear dose-response relationship [1].
Does it help healthy people, or mainly those who are already depleted? Most of the positive human data comes from people who are already ill, with depression, chronic fatigue conditions, or neurodegenerative disease. It’s reasonable to hypothesise that those with the lowest CoQ10 levels have the most to gain from supplementation. But we don’t yet have strong randomised trial evidence in generally healthy middle-aged adults experiencing everyday cognitive fatigue.
Is the fatigue finding real? The 2026 meta-analysis found no significant effect on fatigue, but that finding was based on just two trials with very high variability [1]. It would be wrong to conclude that CoQ10 doesn’t help fatigue; it would equally be wrong to claim it does. Two trials is simply not enough data to know.
Let’s reason through this practically, as a sensible, informed person would.
Here’s what the research supports with reasonable confidence: CoQ10 is central to how your brain generates energy. Its natural production declines with age. Lower blood levels are associated with worse cognitive function in older adults. In people with depression, five RCTs suggest a moderate benefit. In animal models of neurodegeneration, the protective effects are clear and consistent.
Here’s what’s genuinely uncertain: whether supplemented CoQ10 reaches the brain in sufficient quantities to produce neurological effects in humans, and whether it meaningfully reduces everyday cognitive fatigue in otherwise healthy people.
So what would a sensible, informed person actually do?
If you’re over 40 and experiencing cognitive fatigue or low mood, the risk-benefit calculation for CoQ10 is favourable. It’s well-tolerated at standard doses (100–200mg daily is typical in the research literature), has no serious adverse effects [11], and has a plausible, well-established mechanism. The evidence for mood benefits is meaningful, five RCTs pointing the same direction. The evidence for energy and cognitive function is early but credible.
If you’re taking a statin, the case for CoQ10 supplementation is arguably stronger, given statins’ known interference with CoQ10 synthesis [6].
One practical note on form: CoQ10 is fat-soluble, so it’s best absorbed when taken with a meal that contains some fat. Some formulations (ubiquinol, the reduced form) claim better bioavailability than standard ubiquinone, the research on this distinction is ongoing [7].
CoQ10 won’t reverse Alzheimer’s disease. It probably won’t make you feel like you’re 25 again. But as a daily habit for someone who cares about brain health and energy in midlife, particularly someone whose mitochondria are quietly becoming less efficient with every passing year, the case for supplementation is reasonable, the safety profile is reassuring, and the underlying science is genuinely interesting.
Your brain works hard every single day. It deserves a functioning power supply.
[1] Effects of Coenzyme Q10 Supplementation on Depressive Symptoms and Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2026). *Journal of Clinical Psychopharmacology*. DOI: 10.1097/JCP.0000000000002112 | https://pubmed.ncbi.nlm.nih.gov/41294251/
[2] Mechanistic insights into ubiquinone Q10 in Parkinson’s disease: mitochondrial protection, ferroptosis inhibition, and antioxidant recycling (2025). DOI: 10.1080/13813455.2025.2541698 | https://pubmed.ncbi.nlm.nih.gov/40762836/
[3] Gulf War Illness, Fibromyalgia, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Overlap in Common Symptoms and Underlying Biological Mechanisms: Implications for Future Therapeutic Strategies (2025). *International Journal of Molecular Sciences*. DOI: 10.3390/ijms26189044 | https://pubmed.ncbi.nlm.nih.gov/41009608/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12469932/
[4] Coenzyme Q10 and the Blood-Brain Barrier: An Overview (2025). https://pubmed.ncbi.nlm.nih.gov/40283578/
[5] Coenzyme Q (2025). *Metabolic Brain Disease*. DOI: 10.1007/s11011-025-01721-8 | https://pubmed.ncbi.nlm.nih.gov/41182484/
[6] Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases (2023). https://pubmed.ncbi.nlm.nih.gov/37946741/
[7] Preclinical and Clinical Role of Coenzyme Q10 Supplementation in Various Pathological States (2022). DOI: 10.1055/a-1835-1738 | https://pubmed.ncbi.nlm.nih.gov/35724675/
[8] Coenzyme Q10 Levels Associated With Cognitive Functioning and Executive Function in Older Adults (2023). *Nutrients*. https://pubmed.ncbi.nlm.nih.gov/35908233/
[10] Mitochondrial dysfunction and chronic disease: treatment with natural supplements (2014). https://pubmed.ncbi.nlm.nih.gov/24473982/
[11] Coenzyme Q10 effects in neurological diseases (2021). *Physiological Research*. DOI: 10.33549/physiolres.934712 | https://pubmed.ncbi.nlm.nih.gov/35199552/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054193/
[12] Mitochondrial Dysfunction and Chronic Disease: Treatment With Natural Supplements (2014). https://pubmed.ncbi.nlm.nih.gov/26770107/
[14] Early-onset motor impairment and increased accumulation of phosphorylated α-synuclein in the motor cortex of normal aging mice are ameliorated by coenzyme Q (2016). https://pubmed.ncbi.nlm.nih.gov/27143639/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Mild cognitive impairment is a grey zone between normal age-related memory changes and dementia, and it may be
Quick Read Your brain has a nightly cleaning system called the glymphatic system that removes toxic waste proteins during deep
